This presentation includes estimates and forward-looking statements within the meaning of US federal securities laws. These estimates and forward-looking statements are based mainly on our current expectations and estimates of future events and trends that affect or may affect our business, financial condition, results of operations, cash flow, liquidity, and the trading price of our preferred shares, including in the form of ADSs. Although we believe these estimates and forward-looking statements are based ...

Achieves Record First Quarter Operating Results and Record Bookings Introduces PROPEL, Ambitious Targets Designed to Reflect Continued Earnings Growth Momentum Through 2029 First Quarter 2026 Earnings Presentation 1 Disclaimers, Forward Looking Statements and Responsibility Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-looking state ...

DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain forward-looking statements. These statements are not historical facts and are based on the Company's current vision and estimates of the Company's management regarding future economic and other circumstances, industry conditions, performance and financial results, including any potential or projected impact related to Alagoas and related legal proceedings on the Company's business, financial condition and operating results. The wo ...

Q4 2025 Financial Results and Business Updates March 27, 2026 For Investor communication only. Not for use in product promotion. Not for further distribution. 3 • Welcome and Introduction: Amanda Cray, ED, Investor Relations & External Communications • Operational Highlights: Dr. Christian Itin, CEO • Financial Results: Rob Dolski, CFO • Upcoming Milestones and Conclusion: Dr. Christian Itin, CEO • Q&A: Dr. Christian Itin and Rob Dolski Developing and Delivering a New Generation of T Cell Therapies Strong f ...

Investor Presentation 4Q and Full Year 2025 March 2026 Disclaimer This presentation contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company' ...

Q4 and Full Year 2025 March 26, 2026 Replay Dial-in Information Toll Free: 1-844-512-2921 or 1-412-317-6671 Live Presentation Friday, March 27, 2026, 8:30 AM (ET) Participant Dial-in Information Toll Free: 1-800-343-4136 Toll/International: 1-203-518-9843 Conference ID: SANUWAVE OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1753775&tp_key=6ca0a4cd2b Replay Pin Number: 1161147 Replay Expiry: April 10, 2026 2 Forward Looking Statements and Non-GAAP F ...

An emerging leader in Bitcoin mining Fourth Quarter & Full Year 2025 Earnings Presentation Nasdaq: LMFA Forward -Looking Statements This presentation may contain forward -looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," and "project" and other similar words and expressions are intended to signify forward-looking statements. Forward -looking statements are not guarantees of future results a ...

March 27, 2026 25 45 70 •‧‧‧‧‧‧‧‧••‧‧‧••‧‧•‧ The Metals Company (Nasdaq: TMC) – Unlocking the World's Largest Undeveloped Resource of Metals for Energy, Defense, Manufacturing and Infrastructure 2 Nasdaq: TMC Forward looking statements. 0 145 255 253 226 83 169 170 174 249 50 0 115 175 210 Master Headline | Arial 25, Bold Headline | Arial 21, Bold BLUE SUBHEAD | Arial 12, all caps Subhead | Arial 16, Bold Body Copy | Arial 14 For Bullets, use - 115 175 210 25 45 70 0 145 255 253 226 83 169 170 174 249 50 0 ...

Agilent Advanced Therapeutics Click to Edit Master Title Style Strategic Growth in Specialty CDMO March 27, 2026 Click to edit Master subtitle style Safe harbor This presentation contains forward-looking statements (including, without limitation, statements on Agilent's (the "company" or "our") strategy, priorities, growth and growth opportunities, productivity, reinvestment, customer focus, evolving product mix, work environment and innovation plans; our revenue, revenue growth, operating margin and margin ...

2026 Corporate Presentation Advanced Technology That Makes Water Better Robert Banks, President and CEO Nephros provides leading filtration solutions to a variety of industries including healthcare, hospitality, institutions, government, and manufacturing Nephros water filters support medical and commercial use, with options for contaminants like scale or sediment, and FDA-cleared Class II products for infection control and dialysis water or bicarbonate concentrate Safe Harbor Statement Certain statements i ...